Sentences with phrase «when drug companies»

When drug companies put profits before the health and safety of patients, they should be held accountable for their actions.
When drug companies are negligent, they should be held accountable for their actions.
When drug companies realized the potential to expand stimulant sales to adults, they devised a new market, to which Schwarz attributes the rising recreational use of ADHD drugs by students, professors, shift workers, doctors and others with demanding schedules.
Universities are particularly sensitive to university space, resources and / or faculty being involved in outside activities during their working hours, and also for potential conflicts of interest, in which your university research could be biased by receiving outside funding from an inappropriate source, as when a drug company has a vested interest in the outcome of your independent research.

Not exact matches

But when they broached the idea of developing such a vaccine with drug companies, nearly all of them said, «No, thank you very much, but we're not interested,» recalls Schiller in a Lasker Foundation interview.
«When you put these two things together, you've got a novel new drug,» says Steve Gilman, the company's chief scientific officer.
«When you have a drug company up against a difficult disease that many others have failed to cure, be more skeptical.
On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.
Capping off 2017, the company say its stock jump 3.9 % when Metro Inc. began selling back the majority of its Couche - Tard shares — about $ 1.55 billion worth — to help fund its purchase of sister drug store chain Jean Coutu Group Inc..
And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of drug prices, then single - handedly tanked stocks of private - corrections companies when she tweeted about prison reform.
On the surface, Papa seems to have gotten an extraordinarily generous deal to turn around the beleaguered drug company: Not only is his salary more than twice what it was when he was CEO of Perrigo (prgo), a company nearly three times as valuable as Valeant (vrx), it's also especially good considering Valeant's stock price has fallen nearly 67 % since he took over.
«When it comes to making iPhones, it is detrimental to your company to drug test employees,» Williams says, half in jest.
KIND bars faced some problematic press in 2015 as well, when a warning letter from the U.S. Food and Drug Administration said several of the company's products weren't as healthy as advertised.
How about buying a global pharmaceutical company Sterling Drug when you are Eastman Kodak?
The other thing that concerns me is when other drug companies like Pfizer, the ones that you may have in mind, are about to raise prices.
Edwin Matos co-founded drug - safety consulting company BioPoint in 2011, but his dreams of becoming a successful business owner began long before that, when he was the young son of immigrants growing up in the Bronx.
Revenue growth has slowed as many companies sink more resources into developing the next blockbuster drug; what's more, the «patent cliff» for the last round of megabillion - dollar drugswhen generics firms typically see a sales spurt — happened a few years ago.
Her company, Sprout Pharmaceuticals, made headlines in August when a drug it created became the first FDA approved drug to boost a woman's sex drive.
The company has developed an injectable liquid that turns solid when it enters the body to aid in (among other things) drug delivery; it's also invented a polymer - based artificial muscle — similar to Rajagopalan's abandoned PhD project — used in compression wear to counter pain.
When Sarepta Therapeutics nabbed a pioneering approval for a Duchenne muscular dystrophy (DMD) drug last year, it won more than just bragging rights and a controversial FDA approval: the firm also landed a coveted «priority review voucher,» which can either be sold off to another company or used to slash the review period for a future Sarepta treatment.
In fact, if you believe Ackman's math, Valeant goes from one of the industry's stingiest companies when it comes to R&D, as critics contend, to one of the biggest spenders on drug research.
Her seemingly well - orchestrated announcement of diabetes along with a sponsorship deal with a diabetes drug company came off as insincere to many at the time, especially when they also perceived that the lifestyle her brand promotes could be a contributing cause.
The company said a late - stage trial of its cancer drug Abraxane met its main goal of improving the patient's time of survival without worsening skin cancer, when compared to standard chemotherapy.
Now Mylan appears to be learning the same hard lesson this week that Martin Shkreli and Valeant (vrx) learned last year: Investors love when pharmaceutical companies raise drug prices — until everybody else gets really upset about it.
Such big winners stopped showing up a few years ago, leaving the large drug companies watching the calendar for the day when earnings would be hurt by the loss of key patent protections.
Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals companies have long made when facing criticism over drug prices.
The Ranbaxy debacle crossed a crucial threshold in the fall of 2004, when a senior company executive disclosed to a subcommittee of the Board of Directors that the company had committed a massive and ongoing fraud, and that over 200 drug products in more than 40 countries had been submitted to regulators with elements of fabricated data.
On November 21st, a relatively small biotech company named Gilead Sciences (GILD) made headline news in the pharmaceutical investment community when it acquired a little - known hepatitis C drug developer named Pharmasset Inc. (VRUS), for $ 10.8 billion, in an all - cash deal.
Things got even better for Sprout a day after the F.D.A. approval, when Valeant Pharmaceuticals International, a drug company whose deal - making acumen had made it a stock - market darling, bought Sprout for an astonishing $ 1 billion — twice its value just two months earlier.
She added that Mylan had responded promptly when the Food and Drug Administration criticized the company's advertisement in 2012, and that the EpiPen had become more expensive because Mylan had invested in public awareness and improving the device.
Drug companies became a favorite villain during the presidential campaign when Democratic candidates Hillary Clinton and Bernie Sanders beat on «Pharma Bro» Martin Shkreli for raising a drug price 5,00Drug companies became a favorite villain during the presidential campaign when Democratic candidates Hillary Clinton and Bernie Sanders beat on «Pharma Bro» Martin Shkreli for raising a drug price 5,00drug price 5,000 %.
Nevertheless, when one reads, for instance, of how the Eli Lilly company used homeless alcoholics for testing experimental drugs, it is hard not to believe that such guinea pigs are being exploited, even if they may welcome their improved living conditions during the course of the research.
It is true that pharm companies are making HUGE adjustmens to the pricing of these drugs when being sold and distributed to people here.
When I think about the millions of Americans who can not afford basic healthcare while insurance and drug companies announce record profits, I worry.
Dr. King started a pharmaceutical company in Asheville, N.C., to sell homeopathic drugs when he could not get them manufactured to his specifications for his health practice in Ohio.
Jeff left the company in 2003 due to missed work commitments and drug problems, while Matt continued until 2005 when he was released from the company.
I am also, as I have mentioned earlier, concerned that this organization (and others of the same genre) are very similar to the «30 - day wonder» mental health / drug addiction clinics that sprung up across the landscape, back when health insurance companies started authorizing up to 30 - days of in - patient care for such conditions.
It could be argued that these types of gifts are wrong — they certainly can influence prescribing practice — but they're hardly trips to the Bahamas or free cars or whatever else people imagine when they hear «drug company gifts to doctors».
I think people in the U.S. wait on drug companies to tell us when something is okay to take... where were they when our ancestors were already doing this?
«For the past few months I have been working to pass the Erie County Pharmaceutical Water Pollution Act - a bill that would ensure pharmaceutical companies pay their fair share when it comes to the safe disposal of unused prescription drugs.
«We can't do that when the companies continue to pump these out like drug dealers on the street corners.»
The value of stock in a multiple sclerosis drug company - which includes large holdings by members of Congress - collapsed Tuesday when company officials announced the drug failed during recent clinical trials.
When 2 years ago Hackett discovered a new way of using a lipid to link drugs to the soluble protein albumin, and that the combination showed promise in improving the bioavailability of the chemotherapy agent paclitaxel, he and his adviser thought they had an invention that laid the foundation for a company.
It is all too easy for physicians to ignore or miss evidence, particularly when drug or device companies use aggressive marketing to counter reports that could harm sales.
Synergen, a biotechnology company based in Boulder, Colorado, stopped the trial involving 700 patients when interim analysis of data showed that the drug, called Antril, was not working.
In this collaboration, Dickerson designed the synthesis of drugs from precursor compounds prior to scheduling, when they are not available from research supply companies.
Foreign pharmaceutical companies, even those located in low - cost countries, «recognize that when it comes to drugs that can be worth a billion dollars a year, a lot more important than labor costs [is] how quickly can you get through FDA,» Finegold says.
When Theravance, the company in South San Francisco, California, that developed the drug, designed the large phase III clinical trials needed for approval, the FDA simply required a demonstration that the drug eliminated symptoms of infection as reliably as the approved antibiotic vancomycin.
The company was formed in January, when the drug giant Abbott split into two entities, one of them being AbbVie.
Germany's emotionally charged abortion debate was thrown into deeper turmoil last week when MPs discussed whether it was appropriate for them to invite the drugs company Hoechst to market the «abortion pill» RU486 in Germany.
a b c d e f g h i j k l m n o p q r s t u v w x y z